The clinical remission and clinical response rates for the group with repeat infusions of 10 mg/kg of infliximab during the maintenance period were better than the group with 5 mg/kg, but the differences did not reach statistical significance.
← all excerpts
Tracing the historical foundations of infliximab in Crohn's disease treatment: a cited reference analysis.
1
—
—